The pharmaceutical industry is one of the last to be transformed by the digital revolution. But companies like Roche and Novartis have been experimenting for a long while, and the fruits are finally ripening.

Medullan CEO Ahmed Albaiti is a digital health pioneer. In this episode of the HealthBiz podcast, he takes us on a trip down the memory lane of digital health, sharing pharma’s successes and failures. We discuss the shock brought on by COVID-19 and why software is often classified as a medical device. He also shares his vision for an integrated and harmonized future for pharma, payers, providers --and patients.

Show notes:

Ahmed’s LinkedIn profile https://www.linkedin.com/in/ahmed-albaiti-211944/
Medullan https://www.medullan.com/
Nudge: Improving Decisions About Health, Wealth, and Happiness, by Richard Thaler and Cass Sunstein https://yalebooks.yale.edu/book/9780300122237/nudge
Health Business Group https://healthbusinessgroup.com/
David’s LinkedIn profile https://www.linkedin.com/in/davideugenewilliams/

As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:

Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
YouTube https://www.youtube.com/@CareTalkPodcast
CareTalk website https://www.caretalkpodcast.com/

Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.

Episodes through March 2025 were produced by Dafna Williams.

Pharma jumps into digital health: Medullan’s Ahmed Albaiti